Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Amlogenyx Logo
Amlogenyx Growth Score
89
CB Rank
45767
Heat Score
57
Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.
Founded
obfuscation
PrivateSeed Somerville, Massachusetts, United States1-10 www.amlogenyx.com
Biotechnology
Genetics
Therapeutics
Overview

Amlogenyx
Total Funding
obfuscation
Growth Score
89
Heat Score
57

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score89
-2 pts
in past quarter
Heat Score 57
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Amlogenyx

CB Rank
45767
Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease.
Founded
obfuscation
PrivateSeed Somerville, Massachusetts, United States1-10 www.amlogenyx.com
Biotechnology
Genetics
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name Amlogenyx Inc
Operating Status Active
Company Type For Profit
About the Company
Amlogenyx is a novel gene therapeutics company that focuses on developing lysosome-based treatments for Alzheimer's disease. It is a spin-off from Ultragenyx Pharmaceutical.
Phone Number +1 415-231-3300
Contact Email info@amlogenyx.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Gene Therapy for Alzheimer's Disease
A gene therapy approach delivering lysosomal protease PPCA to reduce amyloid plaque accumulation in the brain to treat Alzheimer's disease.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed
obfuscation
Seed Round - Amlogenyx Logo
Seed Round - Amlogenyx
2
obfuscation
GordonMD Global InvestmentsSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•May 13, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Mar 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 2, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 2, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

338
-50.94%
 in past month

IT Spend

$147.4KThis year, Amlogenyx is projected to spend $147.4K on IT, according to Aberdeen.

Active Website Tech Count

3Amlogenyx is actively using 3 technologies for its website, according to BuiltWith. These include Common Crawl, CommonCrawl Top 50m, and  Cloudflare Network Error Logging.
Sub-Organizations
Frequently Asked Questions

Where is Amlogenyx's headquarters? Amlogenyx is located in Somerville, Massachusetts, United States.Who invested in Amlogenyx? Amlogenyx has 2 investors including GordonMD Global Investments and  Ultragenyx Pharmaceutical.When was the last funding round for Amlogenyx? Amlogenyx closed its last funding round on
obfuscation
from a Seed round.Who are Amlogenyx's competitors? Alternatives and possible competitors to Amlogenyx may include Eli Lilly, Roche, and  LEXEO Therapeutics.How much funding has Amlogenyx raised to date? Amlogenyx has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|